^
    No biomarker
    Marginal Zone Lymphoma
    umbralisib
    Sensitive
    :
    A1
    No biomarker
    Marginal Zone Lymphoma
    ibrutinib
    Sensitive
    :
    A1
    No biomarker
    Marginal Zone Lymphoma
    R-CVP
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    R-CHOP
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    rituximab + lenalidomide
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    axicabtagene ciloleucel
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    obinutuzumab
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    idelalisib
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    duvelisib
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    copanlisib
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    chlorambucil
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    ibritumomab tiuxetan
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    lenalidomide + obinutuzumab
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    G-CHOP
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    lisocabtagene maraleucel
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    tisagenlecleucel-T
    Sensitive
    :
    A2
    No biomarker
    Marginal Zone Lymphoma
    O-CVP
    Sensitive
    :
    A2
    MYD88 mutation
    Marginal Zone Lymphoma
    ibrutinib
    Sensitive
    :
    C3
    CARD11 mutation
    Marginal Zone Lymphoma
    ibrutinib
    Resistant
    :
    C3
    KMT2D mutation
    Marginal Zone Lymphoma
    ibrutinib
    Resistant
    :
    C3
    MYD88 L265P
    Marginal Zone Lymphoma
    ibrutinib
    Sensitive
    :
    C3
    TNFAIP3 mutation
    Marginal Zone Lymphoma
    ibrutinib
    Sensitive
    :
    C3
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES